PIRBRIGHT INNOVATIONS LIMITED

Company Registration Number:
04394007 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

PIRBRIGHT INNOVATIONS LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

PIRBRIGHT INNOVATIONS LIMITED

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks: 0 0
Debtors:   695,814 140,569
Cash at bank and in hand: 160,303 89,041
Investments:   0 0
Total current assets: 856,117 229,610
Creditors: amounts falling due within one year: 3 (854,117) (227,610)
Net current assets (liabilities): 2,000 2,000
Total assets less current liabilities: 2,000 2,000
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Total net assets (liabilities): 2,000 2,000
Capital and reserves
Called up share capital: 2,000 2,000
Share premium account: 0 0
Revaluation reserve: 00
Other reserves: 0 0
Profit and loss account: 0 0
Shareholders funds: 2,000 2,000

The notes form part of these financial statements

PIRBRIGHT INNOVATIONS LIMITED

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 16 July 2025
and signed on behalf of the board by:

Name: Michael Tsang
Status: Director

The notes form part of these financial statements

PIRBRIGHT INNOVATIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

PIRBRIGHT INNOVATIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 0 0

PIRBRIGHT INNOVATIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Creditors: amounts falling due within one year note

2025 2024 Trade Creditors 499,507 45,341 Accruals 147,870 80,807 Amounts owed to group undertakings 206,730 101,462 Total 854,117 227,610

PIRBRIGHT INNOVATIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Financial commitments

During the year the company entered into a contract for the construction of the Centre for Veterinary Vaccine Innovation and Manufacture . At the end of the year the outstanding commitment in respect of this contract was £5,903k (2024:Nil). There are also three contracts for professional services for this build, with the outstanding commitment at the year-end totalling £159k (2024:Nil). It is expected that these commitments will be settled by the Autumn of 2026.

PIRBRIGHT INNOVATIONS LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

5. Related party transactions

Name of the related party: The Pirbright Institute
Relationship:
Parent Company
Description of the Transaction: Pirbright Innovations Limited is undertaking a design and build contract to provide The Pirbright Institute with a Centre of Veterinary Vaccine Innovation and Manufacturing. During the year the company charged the Institute £1,003,406 (2024: £538,067)
£
Balance at 01 April 2024 538,067
Balance at 31 March 2025 1,003,406